Website review
This review may include AI-generated content and is not individually verified. Domain, certificate and other facts come from the observed data on this page.
What is Cancer Information & Support Society?
The Cancer Information & Support Society (CISS) is an independent Australian organisation that provides information on alternative cancer therapies alongside evaluations of conventional treatments, and offers personal support to people who choose their own treatment path. Its stated position is that cancer is a systemic disease, that emotional factors matter, and that patients should decide their own program after receiving what it calls accurate, unbiased, evidence-based options. It also argues that invasive conventional therapies should be reserved for immediately life-threatening situations where evidence shows more benefit than harm.
What it offers
- Information on alternative and conventional cancer therapies, with detailed material reserved for members (individual and corporate).
- Personal support by phone, email or in person for people following their chosen program.
- An advocacy stance centred on informed choice, "first do no harm" and taking control of one's health.
- Funding through membership fees, donations, bequests and what it describes as unconditional corporate philanthropy, rather than government or commercial interests.
Who it suits, and the trade-offs
It is likely to appeal to someone who feels poorly served by standard oncology pathways and wants to explore complementary or alternative options without being told what to do. The practical trade-off is that this is a membership-based information service, not a clinic, and it is explicit that it is not a substitute for medical advice. Its framing of conventional therapy as something to be used mainly in life-threatening situations sits outside mainstream oncology practice, so anyone using it should treat CISS material as one input rather than a treatment plan.
A concrete next step
If you are weighing a decision, use CISS as a question-generating resource: read its material, then put the specific claims to a clinician who is familiar with both conventional and alternative approaches. For a mainstream counterweight, compare with Cancer Council Australia or National Cancer Institute. If you want the organisation's own detail, start at Cancer Information & Support Society and check current membership terms before joining.
How does CISS support people who choose alternative cancer therapies?
CISS supports people who choose alternative cancer therapies mainly by providing information, personal support, and a framework for making treatment decisions. According to its own description, it gives information about alternative cancer therapies, evaluates conventional therapies, and supports people in their chosen program rather than directing them toward one fixed approach.
What the support involves
- Information about alternative cancer therapies, alongside evaluation of conventional options.
- Help thinking through treatment choices after being given what CISS describes as accurate, unbiased, evidence-based options.
- Personal support in person, by phone, or by email.
- Extra skills for managing a chosen treatment program.
- A stated philosophy that treatment should address body, mind, emotions, and spirit, and that people with cancer should take control of their health.
Who it is for
This is likely to suit someone who wants to explore alternative therapies while still wanting conventional treatments assessed critically, or who wants support for a self-directed program. CISS says detailed information is provided to members, both individual and corporate, and that it is independent of government or private organisations with vested interests. It says it survives on membership fees, donations, and bequests.
Practical trade-offs
The emphasis on patient choice and on conventional therapies being used only in immediately life-threatening situations where evidence shows more good than harm is a distinctive position. That may appeal to people who feel mainstream oncology does not address emotional or spiritual factors. But it also means CISS is not a neutral general cancer information service: its stated beliefs about cancer as a systemic disease and about emotional factors in causation shape what it presents. Anyone using it should treat its material as one perspective and check treatment decisions with a clinician familiar with both conventional and alternative approaches, as CISS's own disclaimer advises.
Next step
If you are considering this route, start by asking CISS what membership includes, whether support is available for your cancer type and stage, and how its information is kept evidence-based. In parallel, ask a qualified oncologist or integrative doctor to review any alternative therapy you are considering, especially for interactions with conventional treatment.
For broader independent cancer information, you can also compare with National Cancer Institute and American Cancer Society.
What does CISS say about mammography for breast cancer screening?
CISS states that it is against routine mammography for breast cancer screening. Its page cites a Cochrane analysis of mammography screening and says that analysis concluded screening leads to treatments that do more harm than good. The organisation uses that as an example of its wider position: because medical interventions can cause harm, they should rest on trial evidence showing the benefits outweigh the harms, and conventional therapies that are invasive should be reserved for immediately life-threatening situations.
That is a strong, contested claim, and it reflects CISS's stated philosophy rather than a neutral summary of screening evidence. CISS describes itself as independent of government and industry funding, and says it provides detailed information to members rather than to all visitors. Its broader message is that people with cancer should take control of treatment decisions after being given what it considers accurate, unbiased, evidence-based options.
How to weigh this if you are deciding about screening
- Treat the CISS page as one advocacy viewpoint, not as a clinical guideline. Screening advice for an individual depends on age, family history, breast density, previous findings and personal risk factors.
- Ask your doctor or a breast clinic to walk through the same evidence CISS cites, including the age groups and time periods covered by the Cochrane review and how later reviews interpret it.
- The practical decision criterion is not "screening good or bad" in the abstract, but whether screening is likely to benefit you personally, what follow-up tests a positive result would trigger, and how you would handle those.
- If you want a second perspective, organisations such as Cancer Council Australia and Breastcancer.org publish patient-facing screening explanations.
A useful next step: write down your age, risk factors and what you would do if screening led to further tests, then discuss those specifics with a clinician who is willing to explain both the benefits and the harms.
How can I become a member of CISS and what information do members receive?
Membership in the Cancer Information & Support Society (CISS) is how you access its detailed material: the organisation states that it provides detailed information only to members, both individual and corporate, and that it keeps going through membership fees, donations and bequests. Joining is therefore the practical step if you want the full therapy information rather than the general material on the public site.
What members receive, according to CISS
- Detailed, comprehensive information on cancer therapies, presented as unbiased and evidence based.
- Information about alternative cancer therapies and support for people who choose them, alongside evaluation of conventional therapies.
- Personal support by phone, email or in person.
- Help building the extra skills CISS considers necessary to follow a chosen treatment programme.
How to join
The site itself is the starting point: look for its membership or join section, where individual and corporate options are described. If the signup route is unclear, use the contact details on the site to ask directly about current membership terms, what the fee covers and how detailed information is delivered. CISS notes it is independent of government and of organisations with vested interests, which is relevant if independence from industry funding matters to you.
Who this suits, and the trade-offs
CISS is aimed at people who want to take control of treatment decisions, and it explicitly frames cancer as a systemic disease in which emotional factors play a significant part. That worldview shapes the information members get. It is not a neutral directory of every option: it argues that most conventional therapies are invasive and should be reserved for immediately life-threatening situations where evidence shows more good than harm, and it cites a Cochrane analysis of mammography for breast cancer screening as an example of harm outweighing benefit.
That stance is the main trade-off. If you want a perspective that questions conventional oncology and takes alternative therapies seriously, this is a rare organised source of that kind. If you want mainstream treatment guidance, you will need to balance it with a conventional source, and CISS's own disclaimer says you should consult a practitioner familiar with both conventional and alternative therapies and with evidence based medicine or informed choice.
A practical way to decide
Before joining, ask yourself two questions. First, do you want one organisation's curated view, or a range of views you compare yourself? Second, will you actually use the personal support, since that is a large part of what membership buys? A reasonable approach is to join and read the detailed material, then take specific claims to an oncologist or a practitioner experienced in both approaches and ask what the evidence is in your situation. For a mainstream counterweight, the National Cancer Institute and American Cancer Society publish treatment information you can set against it, and Cochrane hosts the kind of systematic reviews CISS itself cites, so you can read the original analyses rather than summaries.
Is CISS independent from government and corporate influence?
CISS presents itself as independent: it states that it is not funded or influenced by any government or private organisation with vested interests, and that it survives on membership fees, donations, bequests and unconditional corporate philanthropy. It also says it provides detailed information only to members.
That claim describes CISS's own position rather than an externally verified fact. Two things are worth separating:
- Independence from government funding — CISS explicitly says it takes no government money, which removes one common source of influence.
- Independence from corporate interests — "unconditional corporate philanthropy" is a narrower commitment than refusing corporate money altogether. It means donations come without conditions attached, but it does not mean corporate donors have no relationship with the organisation.
Practical next step: if funding independence matters to your decision, ask CISS directly for its most recent annual accounts or a list of donors above a set threshold, and check whether any donor has a commercial interest in a therapy CISS discusses. A short email to the organisation is usually enough. You can also compare its stated funding model against other cancer information providers such as Cancer Council Australia or National Cancer Institute, which publish funding and editorial policy details.
Decision criterion: treat "independent" as a claim to verify, not a label to accept. If an organisation will not disclose who funds it, that is itself useful information when weighing its treatment advice.
What should I consider before deciding on a cancer treatment program?
Before committing to any cancer treatment program, weigh three things together: the evidence behind each option, how it fits your values and circumstances, and who will support you through it. The Cancer Information & Support Society frames this as taking responsibility for your own choices after being given accurate, unbiased, evidence-based options, and it argues that effective treatment should address body, mind, emotions and spirit. That is a philosophy, not a clinical protocol; use it as a lens for asking better questions rather than as a substitute for medical advice. The site's own disclaimer says you should consult a practitioner familiar with both conventional and alternative therapies who practises evidence-based medicine or informed choice.
Questions worth answering first
- What is the goal? Curative treatment, extending life, controlling symptoms, or supporting quality of life are different aims, and the right program depends on which you are pursuing.
- What does the evidence show? Ask for the trial results behind each option, including how many people were studied and what happened to them. CISS stresses that because interventions can cause harm, treatments should rest on trials showing more good than harm, and it cites a Cochrane analysis of mammography in breast cancer screening as an example of a case where it says harms outweighed benefits. Treat that as the organisation's reading of one analysis, not a settled verdict on screening.
- What are the harms and the unknowns? For each option, ask about side effects, invasiveness, and what happens if it does not work. CISS argues most conventional therapies are invasive and should be reserved for immediately life-threatening situations where benefit is proven — a position many oncologists would dispute for earlier-stage disease, so test it against your own specialist's reasoning.
- How will you judge progress? Agree on scans, markers or symptom measures in advance, so decisions are not made on hope alone.
- What can you realistically sustain? Travel, cost, time, diet changes and emotional load all affect whether a program is workable.
Conventional, alternative, or both
| Consideration | Conventional treatment | Alternative or complementary approaches |
|---|---|---|
| Evidence base | Typically large trials and regulatory review | Varies widely; some supportive care is well studied, others are not |
| Main risk | Side effects and invasiveness | Delayed or replaced effective treatment; interactions with medication |
| Best use | Depends on cancer type, stage and goal | Often as support for wellbeing alongside medical care |
| Decision check | Ask what the trial data show for your situation | Ask what evidence exists and whether it interferes with other treatment |
The practical distinction is between complementary care that supports you during medical treatment and alternative care used instead of it. The second carries the greater risk, particularly where a cancer is treatable.
Support and independence
CISS describes itself as independent of government and industry funding, surviving on membership fees, donations and bequests, and it provides detailed information to members while offering personal support in person, by phone or by email. If ongoing guidance matters to you, ask any organisation how it is funded and whether detailed information sits behind membership. For a second, mainstream perspective, the National Cancer Institute publishes treatment summaries by cancer type, and American Cancer Society offers plain-language guidance on treatment decisions and clinical trials.
A next step
Write down your diagnosis, stage, and goal, then book one appointment where you ask each provider the same five questions above and record the answers. Compare them side by side before deciding, and consider a second opinion from a specialist who is comfortable discussing both conventional and complementary options.
User reviews (0)